Objective: Natural flavonoids (plant pigments) have been shown to inhibit thyroid peroxidase (TPO) in vitro and the growth of thyroid cancer cell lines. We have studied the role of flavonoids on the iodide transport and the growth of the human follicular thyroid cancer cell line (FTC133) which was stably transfected with the human Na þ /I 2 symporter (hNIS). Design and methods: Cells were treated with flavonoids (0.5 -50 mM) for 0, 2, 4 and 6 days; 125 I content and 125 I efflux of the cells and DNA content were measured. Results: Cell growth was inhibited significantly at day 6 by most flavonoids. Eight out of ten flavonoids decreased the 125 I content of the cells at day 4. Morin did not influence the 125 I content of the cells and, surprisingly, myricetin increased the 125 I content of the cells. Kaempferol, apigenin, luteolin and F21388 decreased NIS mRNA expression after 15, 29 and 48 h; after 96 h NIS mRNA returned to normal. Conclusion: As TPO is not present in this cell line, the effects of the flavonoids on the iodide uptake are not related to organification. Myricetin was the only flavonoid studied that increased the influx and decreased the efflux of iodide. The effect of myricetin (decreased growth and increased retention of iodide) can be of therapeutic value in the radioiodide treatment of thyroid carcinoma.
Introduction
Differentiated thyroid carcinoma has an overall favorable prognosis due to its biological behavior and the highly effective primary therapy consisting of total thyroidectomy and radioiodide therapy. The uptake of iodide is an essential step in thyroid hormone synthesis and essential for the treatment of thyroid carcinoma with radioiodide. This transport process is mediated by the Na þ /I 2 symporter (NIS). Rat NIS was cloned in 1996, followed in the same year by human (h)NIS (1 -4) . Alterations in NIS mRNA expression and NIS function are present in various thyroid disorders: iodide deficiency, congenital hypothyroidism, autoimmunity and thyroid carcinoma (5 -11) . In many patients with recurrent or metastatic thyroid carcinoma, radioiodide uptake by metastases is insufficient. In this situation, no effective curative therapies are currently available. Therefore the search for compounds that have both cytotoxic and beneficial effects on radioiodide uptake is of major importance. In this respect, the flavonoids are an interesting class of substances.
Natural flavonoids are plant pigments that are found in our daily diet, such as all edible plants, nuts, grain and fruit. They are hydroxylated polyphenols and can be classified into different categories: flavonols (quercetin, kaempferol, morin, myricetin), flavonones (naringenin), flavones (luteolin, apigenin) and isoflavones (genistein) (12) .
There is evidence that some of the flavonoids can inhibit growth or induce apoptosis of tumor cells, including thyroid cancer cells (13 -16) in vitro. Different mechanisms are involved (13) : they inhibit enzymes, such as protein tyrosine kinase and DNA topoisomerase I and II which are crucial for cellular proliferation (13, 14) .
Apart from inhibiting cell proliferation, flavonoids have effects on thyroid function and thyroid hormone metabolism in vitro and in vivo. Some of the natural flavonoids inhibit thyroid peroxidase (TPO) in vitro (12) and in humans (17) . The synthetic flavonoid F21388 (3-methyl-4 0 ,6-hydroxy-3 0 ,5 0 -dibromoflavone), developed as a thyroid hormone (T 4 ) analog, displaces T 4 from transthyretin (TTR), and inhibits 5 0 -deiodinase activity in vitro (18 -20) . In vivo, F21388 causes tissue-specific changes in thyroid hormone metabolism in the rat (21 -25) .
Thus, although flavonoids may have beneficial properties for the treatment of thyroid carcinoma by inhibiting thyroid cancer growth, it is important to know whether this effect is compromised by negative effects of flavonoids on iodide kinetics, given the documented effects of flavonoids on iodide organification in thyroid follicles. We chose to investigate the effects of flavonoids on follicular thyroid carcinoma using a human follicular thyroid cancer cell line, FTC133. This cell line expresses most proteins present in differentiated thyroid tissue (thyrotropin receptor (TSH-R), thyroglobulin (Tg), thyroid transcription factors TTF-1, PAX-8) in contrast to most poorly differentiated cell lines available, but does not express TPO and hNIS, comparable with many thyroid cancers. However, there are reports that FTC133 cells express lowered levels of thyroid-specific proteins (26) .
In this study we have investigated the effects of several flavonoids on the growth and 125 I content in the follicular thyroid carcinoma cell line FTC133, which is stably transfected with the hNIS (27, 28) .
Materials and methods
The follicular thyroid carcinoma cell line FTC133 (donated by Drs Goretzki and Simon, University of Dü sseldorf, Germany) was stably transfected with hNIS (donated by Dr Jhiang, Ohio State University, OH, USA) and named FTC133-NIS30 as described earlier (27, 28) . The empty vector cell-transfected cell line FTC133-V4 was also used in the experiments. Cells were grown in Dulbecco's modified Eagle's medium and modified Ham's-F12 medium (1:1) supplemented with 10% fetal calf serum and penicillin/streptomycin. The cells were treated with flavonoids in a dose range from 0.5 to 50 mM for 0, 2, 4 and 6 days. The flavonoids used were: myricetin, kaempferol, apigenin, luteolin, morin, quercetin, naringenin, genistein and fisetin (Table 1 ) (Sigma/Aldrich, Aldrich Chemie BV, Zwijndrecht, The Netherlands) and the synthetic flavonoid F21388 (a gift from K Irmscher, Merck, Darmstadt, Germany). Flavonoids (10 mM stock) were dissolved in 10 ml dimethylsulphoxide and 400 ml ethanol. In control conditions, cells were grown with the addition of the solvent only. All experiments were performed in 12-well plates. On each plate, one row of controls was included to correct for minor differences in plate conditions. For that reason, results are expressed as a percentage of the control. The value of the control cells was defined as 100% at each time point (e.g. days 2, 4, 6 or time in 0-120 min). This is specified in the Figure legends. Medium with/without flavonoids was refreshed every other day.
Effects of flavonoids on cell growth
Effects of flavonoids on cell growth of FTC133-NIS30 and the empty vector-transfected cell line FTC133-V4 were measured on days 0, 1, 2, 4 and 6, using a quantitative fluorescent DNA assay. Dose-dependent effects were studied on day 4. Flavonoid concentrations ranged from 0.5 to 50 mM.
Effects of flavonoids on iodide content of the cells
Acute effects of flavonoids on 125 I content 125 I content was measured as previously described (27, 28) . In brief, cells were cultured in 12-well plates and, 24 h before the addition of Na 125 I, the medium was changed to serum-free (27) . For the 125 I content measurements, cells were washed with Hank's balanced salt solution (HBSS) and incubated with 500 ml HBSS containing 0.2 mCi Na 125 I and 1 nM NaI at 37 8C. Iodide efflux Cells were cultured for 4 days with flavonoids (50 mM) and were incubated for 30 min with HBSS containing 1 nM NaI and 0.2 mCi Na 125 I. Thereafter, the cells were washed every 15 min by adding 500 ml HBSS for 2 h. Radioactivity in all fluid fractions was counted.
RT-PCR
After 15, 28, 49 and 96 h of flavonoid treatment, total RNA from the cell lines was isolated and reverse transcribed. The cDNA was used as a template for PCR 
Statistics
All experiments were performed four to six times. Data are expressed as means^S.E.M. or S.D. as indicated in the legends. Within-group differences were analyzed using the paired t-test. Between-group differences were analyzed with an unpaired t-test. SPSS-10 was used for calculations.
A value of P , 0.05 was considered to be significant.
Results

Growth
Growth was assessed by measuring the amount of DNA per well. Table 2 shows the DNA values (mg/well) of FTC133-NIS30 cells and FTC133-V4 cells without flavonoids (controls) after 1, 2, 4 and 6 days. To compare results, data are expressed as percentage of control in Fig. 1 . Growth was inhibited time dependently by most of the flavonoids. Fifty micrograms of luteolin, genistein and F21388 inhibited significant growth by day 2. At day 4, myricetin inhibited growth significantly and at day 6 growth was inhibited by 50 mM morin, apigenin and kaempferol. Naringenin, quercetin and fisetin did not influence growth significantly. Growth was also inhibited by the same flavonoids in FTC133-V4 (data not shown).
Acute effects of flavonoids Table 3 shows the 125 I content of FTC133-NIS30 without flavonoids expressed as a percentage of the total activity of 125 I-Na/well after 5, 10, 20, 40 and 60 min. The effects of the acute addition of 5 mM flavonoids is depicted in Fig. 2A ; only kaempferol decreased the 125 I content significantly at all time points. F21388 decreased 125 I content significantly from 10 min onward. Myricetin increased the 125 I content during the first 10 min, followed by a decrease to control values afterwards. At 50 mM, all flavonoids except myricetin decreased 125 I content at 5 and 10 min (Fig. 2B ). In contrast, myricetin significantly increased 125 I content at all time points. DNA content was not influenced during the incubation period from 5 to 60 min (data not shown). (Fig. 3) . The decrease in 125 I content was not really dose dependent (Fig. 4) . Interestingly, the increase of 35% in 125 I content was observed for myricetin already with 5 mM. Higher concentrations of myricetin did not increase the 125 I content further. At days 4 and 6, the effects of flavonoids on 125 I content were similar to those at day 2 (Fig. 5) . As the FTC133-V4 cells do not express NIS, the iodide uptake with or without flavonoids was negligible.
Iodide efflux
After 4 days of incubation with 50 mM flavonoids, iodide efflux was measured. Figure 6A shows a faster efflux by apigenin, kaempferol, luteolin and F21388. In contrast, myricetin lowered the efflux, leading to a higher retention of 125 I (Fig. 6B) . 
RNA expression
Discussion
The purpose of this study was to investigate whether flavonoids affect growth of follicular thyroid cancer cells and what the effects are on iodide accumulation, apart from the documented effects of flavonoids on iodide organification in thyroid follicles (17) . We found that most flavonoids inhibit growth as well as 125 I content. However, apart from inhibiting growth, myricetin significantly increased iodide influx.
The effects of flavonoids on the follicular thyroid carcinoma cell line FTC133 as observed in this study are in line with the earlier observations on growth in nonthyroid (14) and thyroid carcinoma cell lines (15, 16) . As growth (defined as increased DNA content) is the result of proliferation on one side and necrosis/ apoptosis on the other side, the effects of flavonoids can be attributed to one or more of these aspects. Although the mechanism is not clear, flavonoids may inhibit growth by interference in DNA synthesis and inducing apoptosis (13) .
In this study, we have shown for the first time that natural flavonoids affect the in vitro 125 I content in a stably hNIS-transfected follicular thyroid carcinoma cell line. It had been shown that NIS mRNA and NIS protein expression in FTC133 cells had been induced by retinoic acid, but an increase in functional iodide uptake was not present (31) . Most flavonoids decreased the 125 I content, whereas surprisingly myricetin increased 125 I content by 35% at 5 mM. The effects on 125 I content are not related to the class of flavonoids, i.e. myricetin which increased the 125 I content, kaempferol which decreased the 125 I content and morin and quercetin which did not influence 125 I content all are flavonols. The flavones luteolin and apigenin behaved similarly to the synthetic flavonoid F21388. The structure of the latter is strikingly similar to luteolin (20) . F21388 was included to compare results from earlier studies (21 -24) . This flavonoid was used as a model to study the interactions of flavonoids with the iodide -thyroid hormone system in vivo and in vitro. These differences in effects may be an indication of the differences in the mechanisms of action; many mechanisms may be possible (13) . This is also the case for the differences between acute effects and dose after 4 and up to 6 days of incubation. The absence of a clear dose-dependent effect is probably due to the presence of fetal calf serum in the medium during the incubation with the flavonoids. The maximum effect of myricetin is already obtained with 5 mM. F21388 and luteolin both have a stronger effect with 50 mM than with 20 mM. As both are known to bind TTR, it can be expected that the effect will be lower at the lower concentration, and that when saturation of the binding to TTR is obtained, resulting in higher free flavonoid concentrations, the effects will increase (19, 25) .
The mechanism of action of the flavonoids on iodide uptake is not clear. In the steady state, iodide accumulation is the result of the influx mediated by NIS and of the efflux probably mediated by pendrin, the recently cloned apical iodide transporter, or channels such as the chloride channels (32) . In our experiments, it appears that some flavonoids (kaempferol, apigenin, luteolin) decreased NIS mRNA expression at semiquantitative PCR and from that it can be assumed that the influx will be affected. Other explanations, such as the interference of flavonoids with NIS mRNA half-life may be relevant. Non-genomic interference of flavonoids with NIS activity may also be of relevance as kaempferol inhibited iodide uptake as early as 5 min.
The efflux of iodide was increased by all flavonoids used, with the exception of myricetin. This may help to explain the decrease in iodide accumulation by these flavonoids as well. The increased 125 I content by myricetin appeared to be related to increased influx as well as a decreased efflux. In this latter aspect, the effects of flavonoids on pendrin may be relevant, but no effects on pendrin gene expression were observed. Other transporters are probably involved (32) or the post-translational effects of flavonoids on other proteins involved in the whole chain of iodide metabolism and/or direct effects due to physico-chemical interference with the function of these proteins can play a role. The effects of flavonoids on proteins and enzymes such as topoisomerases, Na þ /K þ -ATPases, heat shock proteins, cell cycle proteins and/or tyrosine kinases are well known (13) .
The main focus on the activity of flavonoids on the thyroid in the literature was directed towards their effect (inhibition) on TPO (1). The cell line used in our studies is devoid of TPO, so the actions of the flavonoids seen here are independent of the organificationdirected action of TPO, but only to the process of influx and efflux of inorganic iodide.
We have concluded that the growth of the follicular carcinoma cell line FTC133 and also 125 I content was decreased by most of the flavonoids. Only myricetin revealed additional beneficial effects on 125 I content. The increased iodide content and decreased efflux, leading to a threefold increased retention of 125 I makes myricetin an interesting candidate for more efficient therapy of thyroid carcinoma. Further studies are necessary to test this hypothesis and to elucidate the underlying mechanisms of the action.
